The Clorox Company (NYSE:CLX) Receives Consensus Rating of “Reduce” from Analysts

The Clorox Company (NYSE:CLX) has received a consensus rating of “Reduce” from the seventeen analysts that are currently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $103.40.

A number of brokerages have recently commented on CLX. Citigroup decreased their price objective on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. TD Cowen lifted their price objective on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. BNP Paribas Exane decreased their price objective on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research report on Tuesday, May 12th. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. Finally, Morgan Stanley reduced their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st.

Insider Buying and Selling

In related news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp grew its stake in Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after buying an additional 282,794 shares during the last quarter. Invesco Ltd. grew its stake in Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after buying an additional 884,751 shares during the last quarter. Geode Capital Management LLC grew its stake in Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after buying an additional 10,060 shares during the last quarter. Van ECK Associates Corp grew its stake in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after buying an additional 426,433 shares during the last quarter. Finally, Two Sigma Investments LP grew its stake in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $99.46 on Thursday. The firm has a 50-day moving average of $96.69 and a 200-day moving average of $105.30. Clorox has a one year low of $84.70 and a one year high of $132.03. The company has a market cap of $12.03 billion, a PE ratio of 16.15, a price-to-earnings-growth ratio of 0.51 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm posted $1.45 EPS. The company’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts forecast that Clorox will post 5.61 earnings per share for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.